Skip to main content
. 2019 Jun 26;20(13):3127. doi: 10.3390/ijms20133127

Table 1.

Characteristics and medication of patients under study.

Characteristics Number/Mean/(%)/(Range)
total (number) 32
female/male (number, %) 12/20 (37.5%/62.5%)
age (years—mean ± stdd., (range)) 65.92 ± 9.84 (46–88)
C-reactive protein (mg/L) 1.48 ± 1.11
medication
non-steroidal antiinflammatory drugs 31 (97%)
steroids (other than prednisolone) n.a.
opioid analgesics 2 (6.25%)
biologicals n.a.
antihypertensive drugs 19 (59.3%)
non-selective beta blockers (β1 and β2) 0 (0%)
selective beta blockers (β1) 8 (25%)
other (AT1, ACE, CCB) 11 (34.4%)

Abbreviation: n.a.—not applicable, stdd.—standard deviation, AT1—angiotensin II type 1 receptor blockers, ACE—Angiotensin converting enzyme (ACE) inhibitors, CCB—calcium channel blockers.